Europe Injectable Drug Delivery Market worth $259.49 billion by 2031
The report "Europe Injectable Drug Delivery Market by Product (Device, Self Injection, Formulation, Solution, Emulsions), Formulation Packaging (Ampoules, Bottles), Therapeutic Application (Obesity, Diabetes, Cancer, Psoriasis), Usage Pattern - Forecast to 2031", is projected to reach USD 259.49 billion by 2031 from USD 178.87 billion in 2026, at a CAGR of 7.7% during the forecast period.
Browse 320 market data Tables and 70 Figures spread through 380 Pages and in-depth TOC on "Europe Injectable Drug Delivery Market by Product (Device, Self Injection, Formulation, Solution, Emulsions), Formulation Packaging (Ampoules, Bottles), Therapeutic Application (Obesity, Diabetes, Cancer, Psoriasis), Usage Pattern - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-injectable-drug-delivery-market-236318160.html
Aging populations, escalation in chronic and autoimmune disease burdens, and growing adoption of biologics and biosimilars in the region are driving robust growth in the injectable drug delivery market in Europe. The growing preference among patients for self-administration, home-based, and personalized therapies is significantly driving the adoption of advanced injectable delivery technologies. Pharmaceutical and biotechnology companies in Europe are closely collaborating with device manufacturers and contract manufacturers to enhance product performance, expand sterile manufacturing capacity, and comply with stringent EU regulatory requirements. Advancements in formulation development, aided by artificial intelligence, the higher deployment of smart and connected injectors, and increased automation levels in aseptic fill-finish and drug-device combination design, support better precision and personalization in dosing. Moreover, the integration of digital health platforms, remote patient monitoring, and continuous manufacturing processes is expected to further boost market growth and advancement across Europe.
By formulation packaging, the ampoules segment accounted for the largest market share in 2025.
The ampoules segment is expected to account for the largest market share in 2025. Ampules are widely adopted and an inexpensive packaging solution for various injectable drug products. They have excellent sterility properties, stability against chemicals, and suitability for production on either a large scale or a small scale. They are used extensively in hospitals and clinics. Well-developed production facilities and acceptance among various authorities make it easy for ampoules to be widely adopted within the European market.
By end user, the long-term care settings segment is expected to grow at the highest CAGR during the forecast period.
The long-term care settings market is expected to have the highest CAGR during the forecast period due to the aging population and growing burden of chronic disorders. Home and facility-based care models are increasingly adopted within Europe. These settings prefer injectable therapies for conditions requiring long-term management, such as diabetes, immunological disorders, and pain management. The adoption of self-injection devices, caregiver-assisted injection devices, and value-based payment systems will drive demand for injectable products within these settings.
Rest of Europe accounted for the largest share of the market in 2025.
As of 2025, the market for injectable drug delivery in Europe was dominated by Rest of Europe. The region has a substantial share of patients and rising expenditure on healthcare. The countries in this region are also emphasizing the adoption of biologics, enhancing hospital facilities, and expanding immunization and chronic disease management services. It is also experiencing higher investments in drug production and the adoption of self-administered injectables.
Key Market Players
The prominent players in the injectable drug delivery market in Europe are BD (US), Baxter (US), Gerresheimer AG (Germany), SCHOTT Pharma (Germany), West Pharmaceutical Services, Inc. (US), Pfizer Inc. (US), Sanofi (France), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), and Johnson & Johnson (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Injectable Drug Delivery Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
